HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diederik De Cock Selected Research

Infliximab (Remicade)

1/2020The risk of uveitis in patients with JIA receiving etanercept: the challenges of analysing real-world data.
1/2020EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Diederik De Cock Research Topics

Disease

25Rheumatoid Arthritis
06/2024 - 01/2015
6Pain (Aches)
11/2022 - 01/2021
4Juvenile Arthritis (Juvenile Idiopathic Arthritis)
01/2021 - 01/2019
3Necrosis
12/2023 - 01/2020
3Fatigue
10/2022 - 01/2021
2Rheumatic Diseases (Rheumatism)
01/2020 - 01/2019
2Infections
01/2019 - 01/2018
1Prostatic Neoplasms (Prostate Cancer)
01/2024
1Arthritis (Polyarthritis)
10/2021
1Asthenopia (Eyestrain)
01/2021
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021
1Connective Tissue Diseases (Connective Tissue Disease)
01/2021
1Uveitis
01/2020
1Phobic Disorders (Phobia)
03/2019
1Leukopenia
03/2019
1Drug Hypersensitivity (Drug Allergy)
03/2019
1Exanthema (Rash)
03/2019
1Drug-Related Side Effects and Adverse Reactions
03/2019
1Macrophage Activation Syndrome
01/2019
1Joint Diseases (Joint Disease)
03/2017

Drug/Important Bio-Agent (IBA)

11GlucocorticoidsIBA
01/2023 - 01/2015
9Methotrexate (Mexate)FDA LinkGeneric
01/2023 - 04/2015
6Rituximab (Mabthera)FDA Link
06/2024 - 01/2017
5Antirheumatic Agents (DMARD)IBA
10/2022 - 01/2015
4Etanercept (Enbrel)FDA Link
12/2023 - 01/2020
3Adalimumab (Humira)FDA Link
12/2023 - 01/2020
3Janus Kinase InhibitorsIBA
12/2023 - 01/2020
3C-Reactive ProteinIBA
11/2022 - 03/2017
3Leflunomide (Arava)FDA LinkGeneric
09/2020 - 01/2020
2tofacitinibIBA
12/2023 - 01/2020
2Tumor Necrosis Factor InhibitorsIBA
10/2022 - 01/2019
2Abatacept (Orencia)FDA Link
10/2022 - 01/2020
2ametantrone (HAQ)IBA
10/2021 - 01/2021
2Tramadol (K315)FDA LinkGeneric
01/2021 - 01/2021
2Opioid Analgesics (Opioids)IBA
01/2021 - 01/2021
2Sulfasalazine (Azulfidine)FDA LinkGeneric
01/2020 - 01/2020
2Infliximab (Remicade)FDA Link
01/2020 - 01/2020
2tocilizumab (atlizumab)FDA Link
01/2020 - 01/2019
1Indicators and Reagents (Reagents)IBA
12/2022
1Prostaglandins AIBA
10/2022
1Interleukin-6 InhibitorsIBA
10/2022
1Biomarkers (Surrogate Marker)IBA
01/2021
1Acetaminophen (Paracetamol)FDA LinkGeneric
01/2021
1Analgesics (Analgesic Drugs)IBA
01/2021
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2021
1Antidepressive Agents (Antidepressants)IBA
01/2021
1Certolizumab PegolFDA Link
01/2020
1baricitinibIBA
01/2020
1upadacitinibIBA
01/2020
1golimumabFDA Link
01/2020
1GLPG0634IBA
01/2020
1sarilumabIBA
01/2020
1Janus KinasesIBA
01/2020
1Biosimilar PharmaceuticalsIBA
01/2020
1EnzymesIBA
03/2019
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2019

Therapy/Procedure

5Therapeutics
01/2023 - 01/2015
3Remission Induction
01/2020 - 01/2015
1Drug Tapering
06/2024
1Prostatectomy (Retropubic Prostatectomy)
01/2024
1Retreatment
01/2024
1Meditation
11/2022
1Ambulatory Care (Outpatient Care)
08/2021
1Aftercare (After-Treatment)
01/2020